Topical steroid withdrawal syndrome may signal a reminder to clinicians to be good stewards of topical treatments, according ...

According to the lawsuit, Sanofi has failed to provide partner Regeneron adequate information regarding the sales of Dupixent ...

Cendakimab fell short of the bar. The antibody hits IL-13, one of the interleukins targeted by Regeneron and Sanofi’s ...

Immunology superstar Dupixent, which first brought Regeneron and Sanofi together in 2007, has entered its megablockbuster era ...

The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...